Aberdeen: Rapid screening test for glaucoma

Licensing opportunity

Glaucoma is a leading cause of irreversible adult blindness, and while there is no cure, early diagnosis can allow disease progression to be stopped.

Current optometry tests have a high false positive rate and do not reliably detect early-stage disease. A new rapid and non-invasive test has been developed for detecting early stage glaucoma by researchers at Aberdeen University.

The test runs on a personal computer and uses the way that humans perceive moving objects to detect abnormalities in visual processing associated with retinal neuropathies such as glaucoma. Performance on the test relates to the degree of neural damage to the retina.

The test may be applicable to other retinal neuropathies such as optic neuritis and diabetes, and is cost-effective, allowing for mass screening. Patents are pending in Europe, the US, China and India.

For more information, visit the project’s page at http://www.university-technology.com/details/rapid-screening-test-for-glaucoma